Skip to main content

Table 1 Patient characteristics on admission, Yemen (2010–2013)

From: High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen

Drug Site Year n Males (%) Age <5 years Temp °C Febrile patientsa ≥37.5
n (%)
Parasitaemia (/μL)
n (%) 95 % CI Mean (SD) Geometric mean (95 % CI)
AS + SP Al-Udayn 2010 85 44 (51.8) 48 (56.5) (45.3–67.2) 37.9 (0.2) 70 (82.4) 3429 (2643–4449)
AS + SP Sharas 2010 93 52 (55.9) 31 (33.3) (23.9–43.9) 37.7 (0.1) 56 (60.2) 9088 (6947–11,890)
AS + SP Tur Bani Qa’is 2010 95 58 (61.1) 38 (40) (30.1–50.6) 37.9 (0.3) 75 (78.9) 14543 (10,325–18,628)
AS + SP Al Qaflaha 2011 90 42 (46.7) 33 (36.7) (26.7–47.5) 37.6 (0.7) 55 (61.1) 3238 (2506–4184)
AS + SP Bajil 2013 102 51 (50.0) 10 (9.8) (4.8–17.3) 38.0 (0.4) 45 (44.1) 7011 (5461–8999)
AL Bajil 2009–10 80 43 (53.8) 7 (8.8) (3.6–17.2 37.6 (0.4) 74 (92.5) 12,606 (8707–18,248)
AL Jabal Al Sharq 2010 95 57 (60.0) 14 (14.7) (8.3–23.5) 37.6 (0.3) 57 (60) 1729 (1399–2137)
AL Tur Bani Qa’is 2013 93 67 (72.0) 8 (8.6) (3.8–16.2) 38.0 (0.1) 81 (87.1) 11,872 (8698–16,203)
  1. aFebrile patients: axillary temp ≥ 37.5 °C